Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients

被引：0
|
作者：
Meier-Stiegen, F. [1 ]
Schneck, H. [1 ]
Blassl, C. [1 ]
Neves, R. Pedro [2 ]
Janni, W. [3 ]
Fehm, T. [1 ]
Neubauer, H. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Forschungslab Life Sci Ctr, Dusseldorf, Germany
[2] Univ Dusseldorf, Dusseldorf, Germany
[3] Univ Frauenklin Ulm, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [21] Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
    Rosin, Justus
    Svegrup, Ella
    Valachis, Antonios
    Zerdes, Ioannis
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 161 - 169
  • [22] Prognostic role of PIK3CA mutational status in cell free DNA (cfDNA) from HER2-positive metastatic breast cancer patients
    Lee, K-H
    Lim, J.
    Min, A.
    Kim, S-G
    Kim, J-E
    Kim, T-Y
    Han, S-W
    Oh, D-Y
    Kim, T-Y
    Im, S-A
    BREAST, 2017, 32 : S66 - S67
  • [23] Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer
    Kodahl, Annette R.
    Ehmsen, Sidse
    Pallisgaard, Niels
    Jylling, Anne M. B.
    Jensen, Jeanette D.
    Laenkholm, Anne-Vibeke
    Knoop, Ann S.
    Ditzel, Henrik J.
    MOLECULAR ONCOLOGY, 2018, 12 (06): : 925 - 935
  • [24] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
    Ruth E. Board
    Andrew M. Wardley
    J. Michael Dixon
    Anne C. Armstrong
    Sacha Howell
    Lorna Renshaw
    Emma Donald
    Alastair Greystoke
    Malcolm Ranson
    Andrew Hughes
    Caroline Dive
    Breast Cancer Research and Treatment, 2010, 120 : 461 - 467
  • [25] Detection of circulating tumor DNA in the PIK3CA mutated breast cancer patients treated with neoadjuvant chemotherapy
    Sato, Ayaka
    Tanabe, Masahiko
    Tsuboi, Yumi
    Ueno, Takayuki
    Takahashi, Shunji
    Seto, Yasuyuki
    Murakami, Yoshinori
    CANCER SCIENCE, 2023, 114 : 2160 - 2160
  • [26] Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
    Board, Ruth E.
    Wardley, Andrew M.
    Dixon, J. Michael
    Armstrong, Anne C.
    Howell, Sacha
    Renshaw, Lorna
    Donald, Emma
    Greystoke, Alastair
    Ranson, Malcolm
    Hughes, Andrew
    Dive, Caroline
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 120 (02) : 461 - 467
  • [27] Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
    Gasch, Christin
    Bauernhofer, Thomas
    Pichler, Martin
    Langer-Freitag, Sabine
    Reeh, Matthias
    Seifert, Adrian M.
    Mauermann, Oliver
    Izbicki, Jakob R.
    Pantel, Klaus
    Riethdorf, Sabine
    CLINICAL CHEMISTRY, 2013, 59 (01) : 252 - 260
  • [28] Heterogeneity of KRAS, NRAS, PIK3CA and BRAF mutational status in primary tumor, lymph nodes and liver metastases obtained from patients with metastatic colorectal cancer
    del Carmen, S.
    Sayagues, J.
    Bengoechea, O.
    Alcazar, J.
    Gervas, R.
    Garcia, J.
    Orfao, A.
    Sarasquete, M.
    Abad, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 396 - 397
  • [29] PIK3CA Mutational Analysis in Patients With Macrodactyly
    Becker, Jakob
    Gross, Ulrike Camenisch
    Weber, Daniel M.
    Weibel, Lisa
    Theiler, Martin
    Brandt, Simone
    Bode, Peter K.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2022, 25 (06) : 624 - 634
  • [30] Clinical feasibility study of a novel sorting system for detecting PIK3CA mutations from captured circulating tumor cells in patients with breast cancer
    Sawada, T.
    Tamura, K.
    Ito, Y.
    Watanabe, M.
    Fujimura, Y.
    Hashimoto, J.
    Yunokawa, M.
    Koh, Y.
    Fujiwara, Y.
    Koizumi, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S139 - S140
12345